UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024193
Receipt number R000027850
Scientific Title CPAP use situation questionnaire research for obstructive sleep apnea syndrome patients
Date of disclosure of the study information 2017/02/01
Last modified on 2018/10/01 08:45:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

CPAP use situation questionnaire research for obstructive sleep apnea syndrome patients

Acronym

CPAP use situation questionnaire research for obstructive sleep apnea syndrome patients

Scientific Title

CPAP use situation questionnaire research for obstructive sleep apnea syndrome patients

Scientific Title:Acronym

CPAP use situation questionnaire research for obstructive sleep apnea syndrome patients

Region

Japan


Condition

Condition

Obstructive sleep apnea syndrome

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Obstructive sleep apnea (OSAS) syndrome causes night hypoxemia. An obstruction of the respiratory tract repeats in oropharynx during sleep. The patient's quality of life decreases with daytime excessive sleepiness, fatigue and lack of vigilance because of a sleep disorder by sleeping frequent apnea, hypopnea.Sleep apnea syndrome has a close relation with cardiovascular disease. In addition, the patient becomes easy to cause a traffic accident and work-related accident.
For treatment, continuously positive pressure breathing therapy is common. The continuously sustained positive pressure breathing therapy prevents the collapse of the pharynx by adding positive pressure to the respiratory tract during sleep. A CPAP is the only cure that the effectiveness to cardiovascular disease including a mind neurological function and the high blood pressure is proved in a previous study, but the patients are required to continue CPAP treatment for a long term because it is not radical treatment. In addition, the CPAP use of an average of five hours is required overnight more than five days a week to get an enough improvement effect.
However, the side effects depend highly individual, and there are differences in continuation and adherence of the treatment.We thought that though the influence on life was clear, the difference of the understanding degree to the disease and the treatment of the patient might be related in the treatment compliance.Therefore we perform "the questionary survey about OSAS and the CPAP" to evaluate an association between disease understanding and treatment adherence.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation of CPAP adherence and questionnaire about understanding of disease.

Key secondary outcomes

The extraction of a questionnaire item participating in poor adherence.
The odds ratio of a questionnaire item participating in poor adherence.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

For all the study participants, I instruct the basic knowledge about OSAS and the CPAP. The instruction contents use a brochure for A4 with an illustration made with easy words and perform it in outpatient department medical treatment orally for three minutes.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient during CPAP management for sleep apnea syndrome in sleep breathing disorder outpatient department of the Fujita Health University Hospital.

Key exclusion criteria

A patient of minority or there is not enough judgement; of the unconsciousness.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuyoshi Imaizumi

Organization

Fujita Health University

Division name

Respiratory medicine department

Zip code


Address

1-98, Dengakugakubo, Kustukake Cho, Toyoake City, Aichi, Japan

TEL

+81-0562-93-9241

Email

mienon@fujita-hu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuki Mieno

Organization

Fujita Health University

Division name

Respiratory medicine department

Zip code


Address

1-98, Dengakugakubo, Kustukake Cho, Toyoake City, Aichi, Japan

TEL

+81-0562-93-9241

Homepage URL


Email

mienon@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University respiratory medicine department

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University respiratory medicine department

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 30 Day

Date of IRB


Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date

2017 Year 10 Month 31 Day

Date of closure to data entry

2018 Year 02 Month 28 Day

Date trial data considered complete

2018 Year 06 Month 30 Day

Date analysis concluded

2018 Year 07 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 09 Month 27 Day

Last modified on

2018 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027850


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name